A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we describe the production and characterization of bioactive agents containing nanodisks. Amphotericin B nanodisks are taken as an example to describe the protocol in a stepwise manner.
The term nanodisk refers to a discrete type of nanoparticle comprised of a bilayer forming lipid, a scaffold protein, and an integrated bioactive agent. Nanodisks are organized as a disk-shaped lipid bilayer whose perimeter is circumscribed by the scaffold protein, usually a member of the exchangeable apolipoprotein family. Numerous hydrophobic bioactive agents have been efficiently solubilized in nanodisks by their integration into the hydrophobic milieu of the particle's lipid bilayer, yielding a largely homogenous population of particles in the range of 10-20 nm in diameter. The formulation of nanodisks requires a precise ratio of individual components, an appropriate sequential addition of each component, followed by bath sonication of the formulation mixture. The amphipathic scaffold protein spontaneously contacts and reorganizes the dispersed bilayer forming lipid/bioactive agent mixture to form a discrete, homogeneous population of nanodisk particles. During this process, the reaction mixture transitions from an opaque, turbid appearance to a clarified sample that, when fully optimized, yields no precipitate upon centrifugation. Characterization studies involve the determination of bioactive agent solubilization efficiency, electron microscopy, gel filtration chromatography, ultraviolet visible (UV/Vis) absorbance spectroscopy, and/or fluorescence spectroscopy. This is normally followed by an investigation of biological activity using cultured cells or mice. In the case of nanodisks harboring an antibiotic (i.e., the macrolide polyene antibiotic amphotericin B), their ability to inhibit the growth of yeast or fungi as a function of concentration or time can be measured. The relative ease of formulation, versatility with respect to component parts, nanoscale particle size, inherent stability, and aqueous solubility permits myriad in vitro and in vivo applications of nanodisk technology. In the present article, we describe a general methodology to formulate and characterize nanodisks containing amphotericin B as the hydrophobic bioactive agent.
Nascent discoidal high density lipoproteins (HDLs) are naturally occurring progenitors of the far more abundant spherical HDL present in the human circulatory system. These nascent particles, also referred to as pre-ß HDL, possess unique and distinctive structural properties1. Indeed, rather than existing as a spheroidal particle, nascent HDLs are disk-shaped. Extensive structural characterization studies on natural and reconstituted discoidal HDLs have revealed that they are comprised of a phospholipid bilayer whose perimeter is circumscribed by an amphipathic exchangeable apolipoprotein (apo), such as apoA-I. In human lipoprotein metabol....
1. Transformation, expression, and purification of scaffold protein component
Bioactive agent nanodisk formulation process
In the ampB-nanodisk formulation procedure described, the reaction is considered complete when the sample appearance transitions from turbid to clear (Figure 1). This change indicates that nanodisks have formed and that the bioactive agent has been solubilized. Oftentimes, bioactive agents absorb light in the visible wavelength region (e.g., ampB, curcumin, lutein, coenzyme Q10) and, in these cases, the sample ado.......
Formulation of a bioactive agent containing nanodisks provide a convenient method to solubilize otherwise insoluble hydrophobic compounds. Because the product bioactive agent nanodisks are fully soluble in aqueous media, they provide a useful delivery method for a wide range of hydrophobic molecules (Table 1). These include small molecules, natural and synthetic drugs, phytonutrients, hormones, etc. The formulation strategy usually follows a standard protocol that must take into consideration the so.......
This work was supported by a grant from the National Institutes of Health (R37 HL-64159).
....Name | Company | Catalog Number | Comments |
Amphotericin B | Cayman Chemical Company | 11636 | ND Formulation & Standard Preparation |
Ampicillin | Fisher Scientific | BP17925 | Transformation & Expansion |
ApoE4-NT Plasmid | GenScript | N/A | Transformation |
Baffled Flask | New Brunswick Scientific | N/A | Expansion & Expression |
BL21 competent E coli | New England Biolabs | C2527I | Transformation |
Centrifuge bottles | Nalgene | 3140-0250 | Expression |
Chloroform | Fisher Scientific | G607-4 | ND Formulation |
DMSO | Sigma Aldrich | 472301 | Standard Prepartation |
Dymyristoylphosphatidylcholine | Avanti Lipids | 850345P | ND Formulation |
Erlenmeyer flask | Bellco Biotechnology | N/A | Expansion & Expression |
Falcon Tubes | Sarstedt Ag & Co | D51588 | Yeast Viability Assay |
Glass borosilicate tubes | VWR | 47729-570 | ND Formulation |
GraphPad (Software) | Dotmatics | N/A | Yeast Viability Assay |
Heated Sonication Bath | VWR | N/A | ND Formulaton |
Heating and Nitrogen module | Thermo Scientific | TS-18822 | ND Formulation |
HiTrap Heparin HP (5 mL) | GE Healthcare | 17-0407-03 | Purification |
Isopropyl β-D-1-thiogalactopyranoside | Fisher Scientific | BP1755 | Expression |
J-25 Centrifuge | Beckman Coulter | J325-IM-2 | Expression |
JA-14 Rotor | Beckman Coulter | 339247 | Expression |
Lyophilizer | Labconco | 7755030 | ND Formulation |
Methanol | Fisher Scientific | A452-4 | ND Formulation |
Nitrogen gas | Praxair | UN1066 | ND Formulation |
NZCYM media | RPI Research Products | N7200-1000.0 | Expansion & Expression |
Pet-22B vector | GenScript | N/A | Transformation |
Petri dish | Fisher Scientific | FB0875718 | Transformation & Expansion |
Quartz Cuvettes | Fisher Brand | 14385 928A | Spectral Analysis |
Shaking Incubator | New Brunswick Scientific | M1344-0004 | Transformation, Expansion, & Expression |
Slide-A-Lyzer Buoys | Thermo Scientific | 66430 | Purification |
SnakeSkin Dialysis Tubing | Thermo Scientific | 68100 | Purification |
SnakeSkin Dialysis Tubing | Thermo Scientific | 88243 | Purification |
Sodium Chloride | Fisher Scientific | S271 | Purification |
Sodium Phosphate dibasic | Fisher Scientific | S374-500 | Purification |
Sodium Phosphate monobasic | Fisher Scientific | BP329-500 | Purification |
Spectra/POR Weighted Closures | Spectrum Medical Industries | 132736 | Purification |
Spectrophotometer | Shimadzu UV-1800 | 220-92961-01 | spectral analysis |
Tabletop Centrifuge | Beckman Coulter | 366816 | ND Formulation |
UVProbe 2.61 (Software) | Shimadzu | N/A | Spectral Analysis |
Vacuum filter | Millipore | 9004-70-0 | Expression & Purification |
Vacuum pump | GAST Manufacturing Inc | DOA-P704-AA | Expression & Purification |
Vortex | Fisher Scientific | 12-812 | ND Formulation |
Yeast | N/A | BY4741 | Yeast Viability Assay |
Yeast Extract-Peptone-Dextrose | BD | 242820 | Yeast Viability Assay |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved